The company said, “While we are currently experiencing challenging SBS industry conditions, we remain confident in the long-term fundamentals of paperboard packaging. We are taking actions to reduce our costs to ensure that we deliver strong cash flows regardless of where we are in the industry cycle. We used proceeds from the sale of our tissue business to de-lever our balance sheet and position ourselves to take advantage of opportunities to grow and diversify our paperboard product portfolio.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLW:
- CLW Earnings this Week: How Will it Perform?
- Everus to replace Clearwater Paper in the S&P 600 at open on 11/1
- Boston Scientific downgraded, Datadog upgraded: Wall Street’s top analyst calls
- Clearwater Paper upgraded to Outperform from Sector Perform at RBC Capital
- Clearwater Paper temporarily suspends operations in Georgia, North Carolina